Spark Therapeutics nets $380mm in FOPO

19:41 EDT 4 Aug 2017 | Elsevier Business Intelligence

Spark Therapeutics Inc. (gene therapies) netted $380.4mm in a follow on public offering of 5.3mm common shares (including ful...

Original Article: Spark Therapeutics nets $380mm in FOPO


More From BioPortfolio on "Spark Therapeutics nets $380mm in FOPO"

Quick Search

Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...